ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

New Tool Found To Cut DNA At Any Position

April 4, 1986

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

NIH Funding Strategies, UICC Fellowships

December 4, 1992

In Brief: Disapproved CCP Wins Appeal; New Review; Trish Greene Named ACS VP For Nursing

February 26, 1988

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999